Svend Aakhus

Svend Aakhus

Auto-generated profile, based on publicly available information

Svend Aakhus

Department of Circulation and Medical Imaging, Faculty of Medicine, Norwegian University of Science and Technology, Norway

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 May 2013 in Ultrasound in Obstetrics & Gynecology
Verified
Journal Article
Closed access
PDF file
MEM. E. Estensen
M. E. Estensen
JBJ. O. Beitnes
J. O. Beitnes
GGG. Grindheim
G. Grindheim
LAL. Aaberge
L. Aaberge
OSO. A. Smiseth
O. A. Smiseth
SAS. Aakhus
S. Aakhus

1 January 2013 in Cardiovascular Diabetology
Verified
Journal Article
Open access
PDF file
AOAnne P Ofstad
Anne P Ofstad
LGLars Gullestad
Lars Gullestad
EOElsa Orvik
Elsa Orvik
SASvend Aakhus
Svend Aakhus
KEKnut Endresen
Knut Endresen
OJOdd Johansen
Odd Johansen
Novel and robust cardiovascular (CV) markers are needed to improve CV morbidity and mortality risk prediction in type 2 diabetes (T2D). We assessed the long term predictive value of 4 novel CV risk markers for major CV events and mortality.


8 September 2014 in BMC Medical Imaging
Verified
Journal Article
Open access
PDF file
JBJørn Bersvendsen
Jørn Bersvendsen
JBJan O Beitnes
Jan O Beitnes
SUStig Urheim
Stig Urheim
SASvend Aakhus
Svend Aakhus
ESEigil Samset
Eigil Samset
Transcatheter aortic valve implantation involves percutaneously implanting a biomechanical aortic valve to treat severe aortic stenosis. In order to select a proper device, precise sizing of the aortic valve annulus must be completed.

21 November 2014 in Scandinavian Cardiovascular Journal
Verified
Journal Article
Closed access
KBKaspar Broch
Kaspar Broch
AAAhmed Al-Ani
Ahmed Al-Ani
EGEinar Gude
Einar Gude
LGLars Gullestad
Lars Gullestad
SASvend Aakhus
Svend Aakhus
Diastolic dysfunction is a major cause of morbidity in heart transplant recipients. A reliable, non-invasive marker of left ventricular (LV) filling pressure would simplify follow-up in these patients. We aimed to test the validity of echocardiographic indices of LV filling pressure in a contemporary population of heart transplant recipients. Eighty-three patients were examined by right-sided heart catheterisation and echocardiography one year after heart transplantation. We explored the association between echocardiographic parameters of LV filling pressure and invasively measured pulmonary capillary wedge pressure (PCWP). Peak early mitral flow velocity divided by septal early mitral relaxation velocity (E/e'(septal)) was the echocardiographic parameter that best correlated with PCWP (r = 0.47; p < 0.001). At a cut-off value of 22, E/e'(septal) could identify patients with a PCWP above 12 mm Hg with a sensitivity of 56% and a specificity of 95%. The E/e' index was moderately associated with LV filling pressure in heart transplant recipients. Echocardiographic parameters of diastolic function should be interpreted with caution when estimating left ventricular filling pressures in this population.

1 June 2017 in Transplantation
Verified
Journal Article
Closed access
JLJørn Petter Lindahl
Jørn Petter Lindahl
RMRichard John Massey
Richard John Massey
AHAnders Hartmann
Anders Hartmann
SASvend Aakhus
Svend Aakhus
KEKnut Endresen
Knut Endresen
TJTrond Geir Jenssen
Trond Geir Jenssen
In recipients with type 1 diabetes, we aimed to determine whether long-term normoglycemia achieved by successful simultaneous pancreas and kidney (SPK) transplantation could beneficially affect progression of coronary artery disease (CAD) when compared with transplantation of a kidney-alone from a living donor (LDK). In 42 kidney transplant recipients with functioning grafts who had received either SPK (n = 25) or LDK (n = 17), we studied angiographic progression of CAD between baseline (pretransplant) and follow-up at 7 years or older. In addition, computed tomography scans for measures of coronary artery calcification and echocardiographic assessment of left ventricular systolic function were addressed at follow-up. During a median follow-up time of 10.1 years (interquartile range [IQR], 9.1-11.5) progression of CAD occurred at similar rates (10 of 21 cases in the SPK and 5 of 14 cases in the LDK group; P = 0.49). Median coronary artery calcification scores were high in both groups (1767 [IQR, 321-4035] for SPK and 1045 [IQR, 807-2643] for LDK patients; P = 0.59). Left ventricular systolic function did not differ between the 2 groups. The SPK and LDK recipients were similar in age (41.2 ± 6.9 years vs 40.5 ± 10.3 years; P = 0.80) and diabetes duration at engraftment but with significant different mean HbA1c levels of 5.5 ± 0.4% for SPK and 8.3 ± 1.5% for LDK patients (P Conclusions In patients with both type 1 diabetes and end-stage renal disease, SPK recipients had similar progression of CAD long-term compared with LDK recipients. Calcification of coronary arteries is a prominent feature in both groups long-term posttransplant.